Search Results - "Berak, Hanna"

Depression and Cognitive Dysfunction in Patients with Chronic Hepatitis C: Correlation with Viral Replication in the Peripheral Blood Mononuclear Cells and Cytokines in Serum by Radkowski, Marek, Kryczka, Tomasz, Szymańska-Kotwica, Bogna, Berak, Hanna, Horban, Andrzej, Pawłowski, Tomasz, Perlejewski, Karol, Laskus, Tomasz

“…Chronic hepatitis C virus (HCV) infection is commonly associated with depression and cognitive dysfunction, the cause of which could be related to the HCV…”
Get full text

CD8 + T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation by Osuch, Sylwia, Laskus, Tomasz, Perlejewski, Karol, Berak, Hanna, Bukowska-Ośko, Iwona, Pollak, Agnieszka, Zielenkiewicz, Magdalena, Radkowski, Marek, Caraballo Cortés, Kamila

“…During chronic hepatitis C virus (HCV) infection, CD8 T-cells become functionally exhausted, undergoing progressive phenotypic changes, i.e., overexpression of…”
Get full text

Double Positive CD4 + CD8 + (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C by Kochanowicz, Anna Maria, Osuch, Sylwia, Berak, Hanna, Kumorek, Aleksandra, Caraballo Cortés, Kamila

“…In chronic hepatitis C (CHC), characterized by exhaustion of T-cell function, increased frequencies of double-positive (DP) (CD4 CD8 ) cells are present in…”
Get full text

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens by Tronina, Olga, Brzdęk, Michał, Zarębska-Michaluk, Dorota, Dybowska, Dorota, Lorenc, Beata, Janczewska, Ewa, Mazur, Włodzimierz, Parfieniuk-Kowerda, Anna, Piekarska, Anna, Krygier, Rafał, Klapaczyński, Jakub, Berak, Hanna, Jaroszewicz, Jerzy, Garlicki, Aleksander, Tomasiewicz, Krzysztof, Citko, Jolanta, Flisiak, Robert

“…Direct-acting antivirals (DAA) regimens have provided hope for eliminating hepatitis C virus (HCV) infection. Patients following ineffective therapy with DAA,…”
Get full text

Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8 week regimen in a real-world setting by Zarębska-Michaluk, Dorota, Piekarska, Anna, Jaroszewicz, Jerzy, Klapaczyński, Jakub, Sitko, Marek, Tudrujek-Zdunek, Magdalena, Tomasiewicz, Krzysztof, Belica-Wdowik, Teresa, Pabjan, Paweł, Lorenc, Beata, Czauż-Andrzejuk, Agnieszka, Tronina, Olga, Krygier, Rafał, Dobracki, Witold, Buczyńska, Iwona, Simon, Krzysztof A., Dybowska, Dorota, Halota, Waldemar, Pawłowska, Małgorzata, Citko, Jolanta, Laurans, Łukasz, Mazur, Włodzimierz, Janczewska, Ewa, Socha, Łukasz, Deroń, Zbigniew, Berak, Hanna, Flisiak, Robert

“…Introduction Non-cirrhotic treatment-naive hepatitis C patients infected with genotype 1 can be treated with ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks, but…”
Get full text

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study by Janczewska, Ewa, Zarębska-Michaluk, Dorota, Berak, Hanna, Piekarska, Anna, Gietka, Andrzej, Dybowska, Dorota, Mazur, Włodzimierz, Belica-Wdowik, Teresa, Dobracki, Witold, Tudrujek-Zdunek, Magdalena, Deroń, Zbigniew, Buczyńska, Iwona, Sitko, Marek, Czauż-Andrzejuk, Agnieszka, Lorenc, Beata, Białkowska-Warzecha, Jolanta, Citko, Jolanta, Laurans, Łukasz, Jaroszewicz, Jerzy, Socha, Łukasz, Tronina, Olga, Adamek, Brygida, Horban, Andrzej, Halota, Waldemar, Baka-Ćwierz, Barbara, Tomasiewicz, Krzysztof, Simon, Krzysztof, Garlicki, Aleksander, Wawrzynowicz-Syczewska, Marta, Flisiak, Robert

“…According to the EASL and AASLD guidelines, the recommended treatment for patients who failed to achieve a sustained virologic response (SVR) on prior…”
Get full text

Ultradeep Pyrosequencing of Hepatitis C Virus Hypervariable Region 1 in Quasispecies Analysis by Radkowski, Marek, Pawełczyk, Agnieszka, Bukowska-Ośko, Iwona, Płoski, Rafał, Laskus, Tomasz, Zagordi, Osvaldo, Caraballo Cortés, Kamila, Berak, Hanna

“…Genetic variability of hepatitis C virus (HCV) determines pathogenesis of infection, including viral persistence and resistance to treatment. The aim of the…”
Get full text

The most difficult to cure with pangenotypic regimens HCV infected population by Flisiak, Robert, Berak, Hanna, Parfieniuk-Kowerda, Anna, Dybowska, Dorota, Tomasiewicz, Krzysztof, Sitko, Marek, Zarębska-Michaluk, Dorota, Mazur, Włodzimierz, Janczewska, Ewa, Klapaczynski, Jakub, Jaroszewicz, Jerzy

Get full text

THU-215 - The most difficult to cure with pangenotypic regimens HCV infected population by Flisiak, Robert, Berak, Hanna, Parfieniuk-Kowerda, Anna, Dybowska, Dorota, Tomasiewicz, Krzysztof, Sitko, Marek, Zarębska-Michaluk, Dorota, Mazur, Włodzimierz, Janczewska, Ewa, Klapaczynski, Jakub, Jaroszewicz, Jerzy

Get full text

THU-367-YI Effectiveness and safety of direct-acting antivirals in the treatment of elderly people infected with HCV by Brzdęk, Michał, Zarębska-Michaluk, Dorota, Tomasiewicz, Krzysztof, Tudrujek-Zdunek, Magdalena, Lorenc, Beata, Mazur, Włodzimierz, Berak, Hanna, Janocha-Litwin, Justyna, Klapaczynski, Jakub, Janczewska, Ewa, Dybowska, Dorota, Parfieniuk-Kowerda, Anna, Anna, Piekarska, Jaroszewicz, Jerzy, Flisiak, Robert

Get full text

WED-493-YI Direct-acting antivirals in women of reproductive age infected with hepatitis C virus by Dobrowolska, Krystyna, Pawłowska, Małgorzata, Zarębska-Michaluk, Dorota, Rzymski, Piotr, Janczewska, Ewa, Tudrujek-Zdunek, Magdalena, Berak, Hanna, Mazur, Włodzimierz, Klapaczynski, Jakub, Lorenc, Beata, Janocha-Litwin, Justyna, Parfieniuk-Kowerda, Anna, Dybowska, Dorota, Anna, Piekarska, Krygier, Rafal, Dobracka, Beata, Jaroszewicz, Jerzy, Flisiak, Robert

Get full text

Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C by Osuch, Sylwia, Laskus, Tomasz, Berak, Hanna, Perlejewski, Karol, Metzner, Karin J., Paciorek, Marcin, Radkowski, Marek, Caraballo Cortés, Kamila

“…During chronic hepatitis C virus (HCV) infection, both CD4 + and CD8 + T-cells become functionally exhausted, which is reflected by increased expression of…”
Get full text

The efficacy of direct-acting antivirals for chronic hepatitis C in patients with the active oncological disease by Dąbrowska, Maria, Jaroszewicz, Jerzy, Sitko, Marek, Justyna, Janocha-Litwin, Zarębska-Michaluk, Dorota, Janczewska, Ewa, Lorenc, Beata, Tudrujek, Magdalena, Parfieniuk-Kowerda, Anna, Klapaczynski, Jakub, Berak, Hanna, Socha, Łukasz, Dobracka, Beata, Dybowska, Dorota, Mazur, Wlodzimierz, Flisiak, Robert

Get full text

FRI-296 - The efficacy of direct-acting antivirals for chronic hepatitis C in patients with the active oncological disease by Dąbrowska, Maria, Jaroszewicz, Jerzy, Sitko, Marek, Justyna, Janocha-Litwin, Zarębska-Michaluk, Dorota, Janczewska, Ewa, Lorenc, Beata, Tudrujek, Magdalena, Parfieniuk-Kowerda, Anna, Klapaczynski, Jakub, Berak, Hanna, Socha, Łukasz, Dobracka, Beata, Dybowska, Dorota, Mazur, Wlodzimierz, Flisiak, Robert

Get full text

Does a detectable HCV RNA at the end of DAA therapy herald treatment failure? by Zarębska-Michaluk, Dorota, Flisiak, Robert, Janczewska, Ewa, Berak, Hanna, Mazur, Włodzimierz, Janocha-Litwin, Justyna, Krygier, Rafał, Dobracka, Beata, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna, Dobrowolska, Krystyna, Rzymski, Piotr

“…The study aimed to assess the phenomenon of achieving sustained virologic response (SVR) in patients with detectable ribonucleic acid (RNA) of hepatitis C…”
Get full text

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era by Brzdęk, Michał, Zarębska-Michaluk, Dorota, Rzymski, Piotr, Lorenc, Beata, Kazek, Adam, Tudrujek-Zdunek, Magdalena, Janocha-Litwin, Justyna, Mazur, Włodzimierz, Dybowska, Dorota, Berak, Hanna, Parfieniuk-Kowerda, Anna, Klapaczyński, Jakub, Sitko, Marek, Sobala-Szczygieł, Barbara, Piekarska, Anna, Flisiak, Robert

“…Nearly 290000 patients with chronic hepatitis C die annually from the most severe complications of the disease. One of them is liver cirrhosis, which occurs in…”
Get full text

Pangenotypic and genotype-specific antivirals in the treatment of genotype 4 infected patients with HIV coinfection by Zarębska-Michaluk, Dorota, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna, Lorenc, Beata, Pawłowska, Małgorzata, Mazur, Wlodzimierz, Sitko, Marek, Janczewska, Ewa, Berak, Hanna, Justyna, Janocha-Litwin, Klapaczynski, Jakub, Tomasiewicz, Krzysztof, Anna, Piekarska, Dobracka, Beata, Krygier, Rafal, Citko, Jolanta, Olga, Tronina, Dobrowolska, Krystyna, Flisiak, Robert

Get full text

Five-years follow-up of cured HCV patients with or without cirrhosis under real-world interferon-free therapy by Flisiak, Robert, Zarębska-Michaluk, Dorota, Janczewska, Ewa, Rogalska, Magdalena, Karpińska, Ewa, Mikuła, Tomasz, Bolewska, Beata, Białkowska, Jolanta, Flejscher-Stępniewska, Katarzyna, Tomasiewicz, Krzysztof, Karwowska, Kornelia, Pazgan-Simon, Monika, Anna, Piekarska, Berak, Hanna, Olga, Tronina, Garlicki, Aleksander, Jaroszewicz, Jerzy

Get full text

Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders by Dybowska, Dorota, Zarębska-Michaluk, Dorota, Rzymski, Piotr, Berak, Hanna, Lorenc, Beata, Sitko, Marek, Dybowski, Michał, Mazur, Włodzimierz, Tudrujek-Zdunek, Magdalena, Janocha-Litwin, Justyna, Janczewska, Ewa, Klapaczyński, Jakub, Parfieniuk-Kowerda, Anna, Piekarska, Anna, Sobala-Szczygieł, Barbara, Dobrowolska, Krystyna, Pawłowska, Malgorzata, Flisiak, Robert

“…It is estimated that 58 million people worldwide are infected with the hepatitis C virus (HCV). Patients with severe psychiatric disorders could not be treated…”
Get full text

Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients by Zarębska-Michaluk, Dorota, Brzdęk, Michał, Jaroszewicz, Jerzy, Tudrujek-Zdunek, Magdalena, Lorenc, Beata, Klapaczyński, Jakub, Mazur, Włodzimierz, Kazek, Adam, Sitko, Marek, Berak, Hanna, Janocha-Litwin, Justyna, Dybowska, Dorota, Supronowicz, Łukasz, Krygier, Rafał, Citko, Jolanta, Piekarska, Anna, Flisiak, Robert

“…The revolution in treatment of patients with chronic hepatitis C virus (HCV) infection dates back to the introduction of direct-acting antivirals (DAAs). The…”
Get full text